The FDA is cracking down on a generic drugmaker that was the subject of a ProPublica investigation last year, citing problems with safety tests that delayed the recall of a faulty medicine linked to deaths in the U.S.
#News #FDA #Medicine #Safety #Drugs #Pharmaceuticals

ProPublica
The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year
In a warning letter, the Food and Drug Administration said Glenmark Pharmaceuticals failed to properly investigate flaws with a generic drug that P...








